Management of cocaine abuse and dependence.
暂无分享,去创建一个
[1] J. Mendelson,et al. Brain perfusion is abnormal in cocaine-dependent polydrug users: a study using technetium-99m-HMPAO and ASPECT. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[2] T. Kosten,et al. Pharmacotherapy for cocaine-abusing methadone-maintained patients using amantadine or desipramine. , 1992, Archives of general psychiatry.
[3] S. Feldman,et al. Differential effects of medial forebrain bundle lesions on adrenocortical responses following limbic stimulation , 1983, Neuroscience.
[4] W. Feuerlein,et al. [Drug addiction and drug abuse]. , 1969, Munchener medizinische Wochenschrift.
[5] M. Chadwick,et al. A double-blind amino acids, L-tryptophan and L-tyrosine, and placebo study with cocaine-dependent subjects in an inpatient chemical dependency treatment center. , 1990, The American journal of drug and alcohol abuse.
[6] K. Preston,et al. Effects of cocaine alone and in combination with mazindol in human cocaine abusers. , 1993, The Journal of pharmacology and experimental therapeutics.
[7] H. Kleber,et al. Psychopharmacological trials in cocaine abuse treatment. , 1986, The American journal of drug and alcohol abuse.
[8] J. Mendelson,et al. Buprenorphine pharmacotherapy for concurrent heroin and cocaine dependence. , 1993 .
[9] G. Badger,et al. Achieving cocaine abstinence with a behavioral approach. , 1993, The American journal of psychiatry.
[10] B. Rounsaville,et al. Naltrexone and coping skills therapy for alcohol dependence. A controlled study. , 1992, Archives of general psychiatry.
[11] B. Rounsaville,et al. A comparative trial of psychotherapies for ambulatory cocaine abusers: relapse prevention and interpersonal psychotherapy. , 1991, The American journal of drug and alcohol abuse.
[12] A. Leon,et al. Fatal injuries after cocaine use as a leading cause of death among young adults in New York City. , 1995, The New England journal of medicine.
[13] H. Kleber,et al. Methylphenidate treatment of cocaine abusers without attention deficit disorder: a negative report. , 1985, The American journal of drug and alcohol abuse.
[14] W. Ling,et al. Cocaine abuse treatment: a review of current strategies. , 1991, Journal of substance abuse.
[15] L. Cregler,et al. Medical complications of cocaine abuse. , 1986, The New England journal of medicine.
[16] J. Wilkins,et al. A multicenter trial of bupropion for cocaine dependence in methadone-maintained patients. , 1995, Drug and alcohol dependence.
[17] A. Giannini,et al. Bromocriptine Therapy in Cocaine Withdrawal , 1987, Journal of clinical pharmacology.
[18] K. Johnson,et al. Neurobiology of cocaine abuse. , 1992, Trends in pharmacological sciences.
[19] R. Weiss,et al. The Role of Psychotherapy in the Treatment of Substance‐Use Disorders , 1994, Harvard review of psychiatry.
[20] J. Jaffe,et al. Treatment of cocaine dependence in methadone maintenance clients: a pilot study comparing the efficacy of desipramine and amantadine. , 1992, The International journal of the addictions.
[21] N. Mello. A Behavioral Analysis of the Reinforcing Properties of Alcohol and Other Drugs in Man , 1983 .
[22] P. Jatlow,et al. Desipramine facilitation of initial cocaine abstinence. , 1989, Archives of general psychiatry.
[23] P. Devenyi,et al. Bromocriptine in cocaine withdrawal--does it work? , 1988, The International journal of the addictions.
[24] H. Kleber,et al. Pharmacologic treatments of cocaine abuse. , 1986, The Psychiatric clinics of North America.
[25] G. Badger,et al. Incentives improve outcome in outpatient behavioral treatment of cocaine dependence. , 1994, Archives of general psychiatry.
[26] J. Mendelson,et al. Effects of cocaine on pulsatile activity of hypothalamic-pituitary-adrenal axis in male rhesus monkeys: neuroendocrine and behavioral correlates. , 1996, The Journal of pharmacology and experimental therapeutics.
[27] T. Kosten,et al. Bromocriptine treatment of cocaine abuse in patients maintained on methadone. , 1988, The American journal of psychiatry.
[28] P. Jatlow,et al. Psychotherapy and pharmacotherapy for ambulatory cocaine abusers. , 1994, Archives of general psychiatry.
[29] C. O'brien,et al. Carbamazepine treatment for cocaine dependence. , 1995, Drug and alcohol dependence.
[30] M. Gold,et al. Single-dose bromocriptine reverses cocaine craving , 1987, Psychiatry Research.
[31] L. Bauer,et al. Carbamazepine treatment of cocaine dependence: a placebo-controlled trial. , 1995, Drug and alcohol dependence.
[32] T. Kosten,et al. A preliminary study of desipramine in the treatment of cocaine abuse in methadone maintenance patients. , 1987, The Journal of clinical psychiatry.
[33] D. Gorelick,et al. Double-blind comparison of carbamazepine and placebo for treatment of cocaine dependence. , 1995, Drug and alcohol dependence.
[34] P. Selwyn,et al. Risk factors for human immunodeficiency virus infection in intravenous drug users. , 1989, The New England journal of medicine.
[35] D. Ziedonis,et al. Buprenorphine versus Methadone Maintenance for Opioid Dependence , 1993, The Journal of nervous and mental disease.
[36] A T McLellan,et al. An Improved Diagnostic Evaluation Instrument for Substance Abuse Patients: The Addiction Severity Index , 1980, The Journal of nervous and mental disease.
[37] J. Halikas,et al. CARBAMAZEPINE FOR COCAINE ADDICTION? , 1989, The Lancet.
[38] Mendelson Jh,et al. Medical progress. Biologic concomitants of alcoholism. , 1979 .
[39] R. Spealman,et al. Antagonism of cocaine self‐administration by selective dopamine D1 and D2 antagonists , 1990, Behavioural pharmacology.
[40] J. Crayton,et al. Current pharmacotherapies for cocaine abuse: a review. , 1993, Journal of addictive diseases.
[41] E. Nestler,et al. Molecular Neurobiology of Drug Addiction , 1994, Neuropsychopharmacology.
[42] D. Ziedonis,et al. Buprenorphine: Dose-related effects on cocaine and opioid use in cocaine-abusing opioid-dependent humans , 1993, Biological Psychiatry.
[43] M W Fischman,et al. The pharmacology of cocaine related to its abuse. , 1989, Pharmacological reviews.
[44] J. Mendelson,et al. Acute effects of cocaine on prolactin and gonadotropins in female rhesus monkey during the follicular phase of the menstrual cycle. , 1990, The Journal of pharmacology and experimental therapeutics.
[45] T. Kosten,et al. Role of opioid antagonists in treating intravenous cocaine abuse. , 1989, Life sciences.
[46] A. Alterman,et al. Amantadine may facilitate detoxification of cocaine addicts. , 1992, Drug and alcohol dependence.
[47] R. Ehrman,et al. Integrating systemic cue exposure with standard treatment in recovering drug dependent patients. , 1990, Addictive behaviors.
[48] P. Goldman-Rakic,et al. Practice guideline for the treatment of patients with substance use disorders: alcohol, cocaine, opioids. American Psychiatric Association. , 1995, The American journal of psychiatry.
[49] T. Crowley,et al. Use of contingency contracts in specialty clinics for cocaine abuse. , 1982, NIDA research monograph.
[50] C. Johanson. Why publish three negative articles on carbamazepine as a medication for the treatment of cocaine dependence? , 1995, Drug and alcohol dependence.
[51] H. Kleber,et al. Cocaine abuse treatment. Open pilot trial with desipramine and lithium carbonate. , 1984, Archives of general psychiatry.
[52] M. Sanfilipo,et al. A Placebo-Controlled Trial of L-DOPA/Carbidopa in Early Cocaine Abstinence , 1993, Neuropsychopharmacology.
[53] C. McDougle,et al. Clinical phenomenology and neurobiology of cocaine abstinence: a prospective inpatient study. , 1991, The American journal of psychiatry.
[54] J. Mendelson,et al. Buprenorphine suppresses cocaine self-administration in rhesus monkeys. , 1989, NIDA research monograph.
[55] A. Falek,et al. Neuroimmunomodulation by opiates and other drugs of abuse: relationship to HIV infection and AIDS. , 1988, Advances in biochemical psychopharmacology.
[56] M. Winniford,et al. Coronary-artery vasoconstriction induced by cocaine, cigarette smoking, or both. , 1994, The New England journal of medicine.
[57] F. Gawin,et al. Outpatient treatment of 'crack' cocaine smoking with flupenthixol decanoate. A preliminary report. , 1989, Archives of general psychiatry.
[58] Gawin Fh,et al. Cocaine abuse: a review of current and experimental treatments. , 1984, NIDA research monograph.
[59] R. Meyer,et al. The Heroin Stimulus , 1979, Springer US.
[60] David F. Musto,et al. The American disease : origins of narcotic control , 1974 .
[61] G. Badger,et al. Participation of significant others in outpatient behavioral treatment predicts greater cocaine abstinence. , 1994, The American journal of drug and alcohol abuse.
[62] H. Kleber,et al. Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Clinical observations. , 1986, Archives of general psychiatry.
[63] R. Spealman,et al. Role of D1 and D2 dopamine receptors in the behavioral effects of cocaine , 1992, Neurochemistry International.
[64] J. Mendelson,et al. Acute Interactions of Buprenorphine with Intravenous Cocaine and Morphine: An Investigational New Drug Phase I Safety Evaluation , 1993, Journal of clinical psychopharmacology.
[65] M. Kuhar,et al. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. , 1987, Science.
[66] S. B. Caine,et al. Modulation of cocaine self-administration in the rat through D-3 dopamine receptors. , 1993, Science.
[67] J. Mendelson,et al. Acute effects of cocaine on anterior pituitary hormones in male and female rhesus monkeys. , 1993, The Journal of pharmacology and experimental therapeutics.
[68] B. Ho,et al. Neurochemical effects of cocaine following acute and repeated injection , 1977, Journal of neuroscience research.
[69] M. Viederman. Grief: normal and pathological variants. , 1995, The American journal of psychiatry.
[70] M. J. Kuhar,et al. The dopamine hypothesis of the reinforcing properties of cocaine , 1991, Trends in Neurosciences.
[71] L. Parsons,et al. Suppression of psychoactive effects of cocaine by active immunization , 1995, Nature.
[72] D. Landry,et al. Antibody-catalyzed degradation of cocaine. , 1993, Science.
[73] R. Chaisson,et al. Cocaine use and HIV infection in intravenous drug users in San Francisco. , 1989, JAMA.
[74] J. Gfroerer,et al. Frequent cocaine users and their use of treatment. , 1993, American journal of public health.
[75] R. Herning,et al. Changes in mood, craving, and sleep during short-term abstinence reported by male cocaine addicts. A controlled, residential study. , 1990, Archives of general psychiatry.
[76] W. Bickel,et al. Buprenorphine treatment of opioid dependence: A review. , 1995 .
[77] J. Hollander. The management of cocaine-associated myocardial ischemia. , 1995, The New England journal of medicine.
[78] F. Bloom,et al. Cellular and molecular mechanisms of drug dependence. , 1988, Science.
[79] J. Feather,et al. Bromocriptine and amantadine in cocaine detoxification , 1989, Psychiatry Research.
[80] J. Mendelson,et al. Buprenorphine attenuates the effects of cocaine on adrenocorticotropin (ACTH) secretion and mood states in man. , 1992, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.
[81] P. Thompson,et al. Acute cardiac events temporally related to cocaine abuse. , 1986, The New England journal of medicine.
[82] M. Kuhar. NEUROTRANSMITTER TRANSPORTERS AS DRUG TARGETS : RECENT RESEARCH WITH A FOCUS ON THE DOPAMINE TRANSPORTER , 1993 .
[83] W. Vale,et al. Cocaine stimulates adrenocorticotropin (ACTH) secretion through a corticotropin-releasing factor (CRF)-mediated mechanism , 1987, Brain Research.
[84] J. Fairbank,et al. Cocaine use by clients in methadone programs: significance, scope, and behavioral interventions. , 1991, Journal of substance abuse treatment.
[85] W. Bickel,et al. Applying behavioral concepts and principles to the treatment of cocaine dependence. , 1994, Drug and alcohol dependence.
[86] F. Gawin. Chronic neuropharmacology of cocaine: progress in pharmacotherapy. , 1988, The Journal of clinical psychiatry.
[87] J. Mendelson. Biologic Concomitants of Alcoholism , 1970 .
[88] A. Alterman,et al. Naltrexone in the treatment of alcohol dependence. , 1992, Archives of general psychiatry.
[89] M. Gold,et al. Psychopharmacology of Cocaine , 1988 .
[90] F. Tennant,et al. Double-blind comparison of amantadine and bromocriptine for ambulatory withdrawal from cocaine dependence. , 1987, Archives of internal medicine.
[91] Tennant Fs,et al. Double-blind comparison of desipramine and placebo in withdrawal from cocaine dependence. , 1984 .
[92] J. Mendelson,et al. Acute effects of cocaine on plasma adrenocorticotropic hormone, luteinizing hormone and prolactin levels in cocaine-dependent men. , 1992, The Journal of pharmacology and experimental therapeutics.
[93] R. Foltin,et al. Smoked and intravenous cocaine in humans: acute tolerance, cardiovascular and subjective effects. , 1991, The Journal of pharmacology and experimental therapeutics.
[94] P. Jatlow,et al. Cocaethylene: pharmacology, physiology and behavioral effects in humans. , 1995, The Journal of pharmacology and experimental therapeutics.
[95] D. Marlowe,et al. Psychiatric Comorbidity in Cocaine Dependence: Diverging Trends, Axis II Spectrum, and Gender Differentials , 1995 .
[96] P. Jacob,et al. Fluoxetine for cocaine dependence in methadone maintenance: quantitative plasma and urine cocaine/benzoylecgonine concentrations. , 1993, Journal of clinical psychopharmacology.
[97] M. Gold,et al. New concepts in cocaine addiction: The dopamine depletion hypothesis , 1985, Neuroscience & Biobehavioral Reviews.
[98] David R. Gastfriend,et al. Buprenorphine Treatment of Opiate and Cocaine Abuse: Clinical and Preclinical Studies , 1993, Harvard review of psychiatry.
[99] J. Jaffe,et al. A controlled trial of buprenorphine treatment for opioid dependence. , 1992, JAMA.
[100] K. Kirby,et al. Fluoxetine is ineffective for treatment of cocaine dependence or concurrent opiate and cocaine dependence: two placebo-controlled double-blind trials. , 1995, Journal of clinical psychopharmacology.
[101] Millman Rb. Evaluation and clinical management of cocaine abusers. , 1988 .
[102] J. Mendelson,et al. Cocaine effects on pulsatile secretion of anterior pituitary, gonadal, and adrenal hormones. , 1989, The Journal of clinical endocrinology and metabolism.